Does TOVORAFENIB Cause Disease progression? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Disease progression have been filed in association with TOVORAFENIB (OJEMDA). This represents 8.0% of all adverse event reports for TOVORAFENIB.
16
Reports of Disease progression with TOVORAFENIB
8.0%
of all TOVORAFENIB reports
2
Deaths
2
Hospitalizations
How Dangerous Is Disease progression From TOVORAFENIB?
Of the 16 reports, 2 (12.5%) resulted in death, 2 (12.5%) required hospitalization.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for TOVORAFENIB.
What Other Side Effects Does TOVORAFENIB Cause?
Accidental underdose (19)
Rash (16)
Fatigue (15)
Off label use (13)
Headache (12)
Hair colour changes (11)
Blood creatine phosphokinase increased (10)
Acne (8)
Intracranial tumour haemorrhage (8)
Dermatitis acneiform (7)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which TOVORAFENIB Alternatives Have Lower Disease progression Risk?
TOVORAFENIB vs TOZINAMERAN
TOVORAFENIB vs TRABECTEDIN
TOVORAFENIB vs TRACLEER
TOVORAFENIB vs TRADJENTA
TOVORAFENIB vs TRALOKINUMAB-LDRM